Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic

This article was originally published here

Pediatr Pulmonol. 2021 Jan 12. doi: 10.1002/ppul.25250. Online ahead of print.


To assess the impact of COVID-19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 versus 2020. Restrictions on social interaction due to the COVID-19 pandemic were associated with a lower number of PEx events at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.

PMID:33434352 | DOI:10.1002/ppul.25250